The Scotts Miracle-Gro (SMG) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
2 Feb, 2026Opening remarks and agenda
Meeting opened with a welcome from the Chairman and CEO, highlighting recent focus on capital structure and balance sheet health.
Agenda included formal business, board introductions, and a Q&A session for shareholders.
Financial performance review
Consistent improvement in performance noted, including significant free cash flow, margin improvement, and EBITDA growth.
Over $1.5 billion in debt paid down, with leverage expected to return to historic norms later in the fiscal year.
Board and executive committee updates
Board members introduced, representing diverse backgrounds in finance, government, technology, and more.
Board actively oversees management and strategic direction.
Partial view of Summaries dataset, powered by Quartr API
Latest events from The Scotts Miracle-Gro
- Hawthorne divestiture, margin gains, and share buyback support improved outlook.SMG
Q1 20264 Feb 2026 - Margin expansion, $150M supply chain savings, and 3% sales growth drive future value.SMG
Investor Day 20243 Feb 2026 - Q3 sales and margins surged, with net income and guidance both sharply improved.SMG
Q3 20242 Feb 2026 - Margin gains, innovation, and free cash flow drive a positive outlook despite topline shifts.SMG
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - 20% EBITDA growth, strong cash flow, and margin gains signal a robust turnaround.SMG
Q4 202416 Jan 2026 - Financial turnaround, board refreshment, and all proposals approved amid strong shareholder support.SMG
AGM 20259 Jan 2026 - Q1 sales and margin gains, U.S. Consumer up 11%, Hawthorne down 35%, outlook reaffirmed.SMG
Q1 20259 Jan 2026 - Strong margin and EPS growth in 2025, with further gains and buybacks expected in 2026.SMG
Q4 202529 Dec 2025 - Proxy covers director elections, pay, auditor ratification, and incentive plan amendment.SMG
Proxy Filing17 Dec 2025